Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × apatinib × Thoracic × Clear all

Status

Sponsor Class

Study Type

Interventional 55 Observational 1

Sponsor

Cancer Type

Gastrointestinal 3 CNS 2 Thoracic 1 Breast 1

Conditions

Lung Neoplasms 1

Interventions

Blood Specimen Collection 33 Surveys and Questionnaires 23 Surgical Procedures, Operative 19 Carboplatin 19 Immunotherapy 16 Drug Therapy 16 pembrolizumab 15 osimertinib 15 Radiotherapy 15 Nivolumab 15 Immune Checkpoint Inhibitors 15 atezolizumab 13 Cisplatin 13 Specimen Handling 12 Observation 12 Gene Expression Profiling 12 Bevacizumab 12 Afatinib 12 Pemetrexed 11 Magnetic Resonance Spectroscopy 11 lorlatinib 10 Immunohistochemistry 10 Biopsy 10 Paclitaxel 9 Erlotinib Hydrochloride 9 alectinib 8 Crizotinib 8 durvalumab 7 Therapeutics 7 Polymerase Chain Reaction 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03376191 2017-12-18

Apatinib in Advanced Non-squamous，NSCLC

Peking University Cancer Hospital & Institute

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡